Selective tubulin-binding drugs induce pericyte phenotype switching and anti-cancer immunity. - He B; Wood KH; Li ZJ; Ermer JA; Li J; Bastow ER; Sakaram S; Darcy PK; Spalding LJ; Redfern CT; Canes J; Oliveira M; et al. (EMBO molecular medicine, 2025)